incretin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | 31 amino acid residues |
| Molecular formula | C187H291N45O59 | free peptide, no counter-ion |
| Approximate mass | 4114 Da | matches theoretical value |
| Receptor target | Glucagon-like peptide-1 receptor | Gs-coupled, cyclic AMP pathway |
| Circulation half-life | About one week in humans | extended by albumin association |
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
== Product life cycle approach in validation == Validation process efforts must account for the complete product life cycle, including developmental procedures adapted for qualification of a drug product commencing with its research and development phase, rationale for adapting a best fit formula which represents the relationship between required outputs and specified inputs, and procedure for manufacturing. Each step is required to be justified and monitored in order to provide a good quality food and drug product. The FDA emphasizes the product life cycle approach in its evaluation of manufacturer regulatory compliance as well.
Although the term nigari is derived from nigai, the Japanese word for "bitter", both nigari and pure magnesium chloride impart very little perceivable taste to the finished tofu. Calcium chloride is not found in seawater in significant quantities and therefore is not regarded as nigari. It is used extensively in the United States due to its flavor and low cost. Fresh clean seawater itself can also be used as a coagulant.
=== New Zealand Cavaliers === A "rebel tour" not government sanctioned went ahead in 1986, but after that sporting ties were cut, and New Zealand made a decision not to convey an authorised rugby team to South Africa until the end of apartheid. This followed the intensely controversial 1981 South African tour New Zealand which had provoked nationwide protest and world-wide condemnation. The Cavaliers tour was very controversial within New Zealand and the players found that support for their actions was far less than they had expected. This controversy meant there were no future rugby contacts until the South African apartheid regime ended. The All Blacks did not tour South Africa until after the fall of the apartheid régime (1990–1994), although after the 1985 tour was cancelled an unofficial tour took place in 1986 by a team that included 28 out of the 30 All Blacks selected for the 1985 tour, known as the New Zealand Cavaliers but often advertised in South Africa as the All Blacks or depicted with the Silver Fern. Of the 30 players who had been selected for the All Black tour, only David Kirk and John Kirwan did not join the Cavaliers. The rebel team were widely believed to have received large secret payments—a controversial issue at a time when rugby union was still supposedly an amateur sport On their return, the NZRFU barred all the players from participating in the next two All Black tests, and instead selected a new group of players. Most of these replacement players were younger, and were quickly dubbed the "Baby Blacks".
short arm Denoted in shorthand with the symbol p. In condensed chromosomes where the positioning of the centromere creates two segments or "arms" of unequal length, the shorter of the two arms of a chromatid. Contrast long arm.
He considered the West Midlands dialect of Middle English to be his own "native language", and, as he wrote to W. H. Auden in 1955, "I am a West-midlander by blood (and took to early west-midland Middle English as a known tongue as soon as I set eyes on it)."
Sources: en.wikipedia.org
They are distinguished by a siliceous skeleton of two and four rayed spicules and contain the protein spongin. Hexactinellid are also called glass sponges, and are distinguished by a six-rayed glass skeleton. These sponges are also capable of carrying out action potentials. Calcareous sponges are characterized by a calcium carbonate skeleton and comprise less than 5% of sponges.
=== Liquid interfaces === Understanding the behavior of nanoparticles at liquid interfaces is essential for integrating them into electronics, optics, sensing, and catalysis devices. Molecular arrangements at liquid/liquid interfaces are uniform. Often, they also provide a defect-correcting platform and thus, liquid/liquid interfaces are ideal for self-assembly. Upon self-assembly, the structural and spatial arrangements can be determined via X-ray diffraction and optical reflectance. The number of nanoparticles involved in self-assembly can be controlled by manipulating the concentration of the electrolyte, which can be in the aqueous or the organic phase. Higher electrolyte concentrations correspond to decreased spacing between the nanoparticles. Pickering and Ramsden worked with oil/water (O/W) interfaces to portray this idea. Pickering and Ramsden explained the idea of pickering emulsions when experimenting with paraffin-water emulsions with solid particles like iron oxide and silicon dioxide. They observed that the micron-sized colloids generated a resistant film at the interface between the two immiscible phases, inhibiting the coalescence of the emulsion drops. These Pickering emulsions are formed from the self-assembly of colloidal particles in two-part liquid systems, such as oil-water systems. The desorption energy, which is directly related to the stability of emulsions depends on the particle size, particles interacting with each other, and particles interacting with oil and water molecules.
Cods of the genus Gadus have three rounded dorsal and two anal fins. The pelvic fins are small, with the first ray extended, and are set under the gill cover (i.e. the throat region), in front of the pectoral fins. The upper jaw extends over the lower jaw, which has a well-developed chin barbel. The eyes are medium-sized, approximately the same as the length of the chin barbel. Cod have a distinct white lateral line running from the gill slit above the pectoral fin, to the base of the caudal or tail fin. The back tends to be a greenish to sandy brown, and shows extensive mottling, especially towards the lighter sides and white belly. Dark brown colouration of the back and sides is not uncommon, especially for individuals that have resided in rocky inshore regions. The Atlantic cod can change colour at certain water depths. It has two distinct colour phases: gray-green and reddish brown. Its average weight is 5–12 kilograms (11–26 pounds), but specimens weighing up to 100 kg (220 lb) have been recorded. Pacific cod are smaller than Atlantic cod and are darker in colour.
== Awards == 1977, Young Investigator award, National Institutes of Health (NIH) 1979, Research Career Development Award, NIH 1983, Recognition Award for Young Scholars, American Association of University Women 1987, John J. Abel Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics (ASPET) Limbird was the second woman to receive this award, the first being Eva King Killam in 1954. 1989, MERIT Award, NIH 1994, Distinguished Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD, now Brain & Behavior Research Foundation). 1998, Distinguished Alumni Award, College of Wooster 2004, Goodman and Gilman Award in Drug Receptor Pharmacology, ASPET 2013, Julius Axelrod Award, ASPET.
The game's production was turbulent, as the design's scope exceeded the available resources, and the team was left without a producer for nearly a year until Activision appointed David Mullich to the role, where he found designs and levels unfinished or abandoned. After three years in development with no end in sight and running over budget, Activision set a strict deadline for completion, and Bloodlines was released incomplete in November 2004. Released in competition with Half-Life 2 and several other titles, Bloodlines sold fewer than 80,000 copies during its initial release, which was considered a poor performance. It received generally positive reviews from contemporary critics, who praised the game's writing and the scale of choice, although they criticized its technical flaws. It was Troika Games's last production before its failure in early 2005, when it could not secure additional projects. The game has a cult following as a rarely replicated example of gameplay and narrative, and modern reception recognizes it as a flawed masterpiece. Since its original release, Bloodlines received post-release support from fans, supplying unofficial fixes and re-adding unused content. A sequel, Vampire: The Masquerade – Bloodlines 2, was released in 2025.
Sources: en.wikipedia.org
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.
The substitution at position 8 removes the site recognised by dipeptidyl peptidase-4, the enzyme that destroys the native hormone within minutes. The linked lipophilic chain then binds circulating albumin, which further limits access by degradative enzymes and reduces renal loss. Together these features lengthen the effective circulation time considerably.
It acts at the glucagon-like peptide-1 receptor, a G protein-coupled receptor that signals mainly through cyclic AMP. Activation is glucose dependent, meaning insulin release is stimulated more strongly when blood glucose is already elevated. Other tissues carrying the same receptor respond as well, which explains effects beyond glucose control.
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.